PDE4A and chronic obstructive pulmonary disease: Underlying our findings of PDE-inhibitors influencing the epithelium, Moodley et al. determined the impact of PDE4-inhibitor in combination with inhaled corticosteroids and β2-adrenoreceptor agonists on pulmonary bronchial epithelium in terms of COPD in vitro [37].